Davis and Wagener (IMAGE)
Caption
At The Ohio State University in Columbus, Ohio, Alan Davis, PhD (left) and Theodore Wagener, PhD (right) developed the first-ever clinical trial treating lung cancer patients with psilocybin-based therapy.
Credit
The Ohio State University Comprehensive Cancer Center
Usage Restrictions
All multimedia is available for free with courtesy to The Ohio State University Comprehensive Cancer Center.
License
Original content